Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Gorilla Technology and SINTRONES Partner to Develop In-Vehicle AI Computing Capabilities
-
Foresight Announces First Quarter 2024 Financial Results
-
Sonnet BioTherapeutics to Present SB221 as a Trial in Progress at the ASCO 2024 Annual Meeting
-
Kandi Shines at Thailand Golf Cart Expo, Expands in Southeast Asia
-
Corcept Announces Primary Endpoint Met in Pivotal Phase 3 GRACE Trial of Relacorilant in Patients With Hypercortisolism (Cushing’s Syndrome)
-
Clarametyx Biosciences Appoints Renowned Experts to Augment Strategic and Scientific Advisory Boards
-
Bionano Announces Private Placement of Senior Secured Notes in Debt Restructuring that Improves Balance Sheet
-
NEVADA CANYON SIGNS LAPON CANYON ROYALTY AGREEMENT
-
CARGO Therapeutics Announces $110.0 Million Private Placement Equity Financing
-
Menten AI Announces Completion of Research Collaboration with Bristol Myers Squibb
-
Vera Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for Atacicept in Immunoglobulin A Nephropathy (IgAN)
-
iLearningEngines Expects to Join the Russell 3000® Index
-
Cerro de Pasco Resources is Granted a Long-Awaited Land Easement for its Quiulacocha Project, Peru
-
Nanox Announces First Quarter of 2024 Financial Results and Provides Business Update
-
PCC and Massive Bio Validate Existing AI System in Groundbreaking and Largest Multi-Sponsor Clinical Trial Matching Study
-
Latest Survey from Grayscale Investments® and The Harris Poll Uncovers Likely American Voters Increasingly Becoming Crypto Investors
-
Citco: NAV Lending Grows Rapidly as Heightened Disclosure Looms
-
CryptoHeap to Include Major Cryptocurrencies in Updated Staking Options
-
Lantheus to Present at the William Blair 44th Annual Growth Stock Conference
-
DYPER™ Announces Appointment of Giusy Buonfantino as New CEO
-
Tokio Marine HCC – Specialty Group and Susan G. Komen® Pair Up With World No. 1 Golfer Nelly Korda to Help End Breast Cancer
-
Invitation to ScottsMiracle-Gro’s “Meet the Management” Investor Day in Marysville, Ohio
-
Nano® Hearing Aids and Soundwave Hearing Forge Strategic Partnership to Expand Accessibility to Sontro® Self-Fitting OTC Hearing Aid
-
Gabelli Funds to Host 16th Annual Media & Entertainment Symposium Thursday, June 6, 2024
-
Kratos Defense Celebrates the 200th Launch of the BQM-177A in Support of U.S. Navy Exercises
-
Definitive Healthcare Appoints Kevin Coop as CEO for Next Phase of Company’s Growth
-
Gabelli Funds to Host 16th Annual Media & Entertainment Symposium Thursday, June 6, 2024
-
LevLane Advertising Wins PRSA Anvil Award for Best Feature Article Addressing Bias Against Use of Biological Terms in Women's Health Marketing and Advertising
-
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
-
Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
-
Decisions of the Annual General Meeting of AS Pro Kapital Grupp shareholders
-
Wood Mackenzie names new leader for Consulting
-
UEFA Grants Exclusive Rights to Hisense as Official VAR Screen Provider for UEFA EURO 2024™
-
Vista Outdoor Rejects Unsolicited Indication of Interest from MNC Capital
-
Alliance Trust PLC - Net Asset Value
-
Vista Outdoor Confirms CSG Increases Purchase Price for The Kinetic Group Business by $50 Million to $1.96 Billion
-
Granite Creek Copper Announces 2024 Exploration Program at Carmacks Project in Yukon, Canada
-
Electric Royalties Provides Seven Updates on Its Lithium, Graphite, Copper, Nickel, and Tin Royalties
-
NeuralAI Launches AI 3D Asset Generator with TAO Bittensor Subnet: Transforming 3D Model Creation for Games and Beyond
-
Shoulder Innovations Unveils New Humeral Preoperative Planning Feature with ProVoyance Shoulder
-
Affinia Therapeutics to Participate in the 2024 Jefferies Global Healthcare Conference
-
CAE, INC. ALERT: CAE, Inc. Falls after Announcing Impairment Charges (NYSE: CAE) – Investors are Encouraged to Contact BFA Law About Your Rights
-
Dopavision Announces Topline Results in Clinical Trial of Targeted Photobiomodulation Approach for Progressive Myopia
-
Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey Therapeutics Including Rights to NM26, a Bi-Specific Antibody for the Treatment of Atopic Dermat
-
Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey Therapeutics Including Rights to NM26, a Bi-Specific Antibody for the Treatment of Atopic Dermatitis
-
Entourage Health Reports First Quarter 2024 Financial Results: Achieves $16.4 Million in Total Revenue and Marks First EBITDA-Positive Quarter
-
Inter&Co doubles down on SMEs through acquisition of Granito
-
Unyted and INU Launch INUVERSE: The Future of Immersive Education
-
Inter&Co doubles down on SMEs through acquisition of Granito
-
T-Mobile to Acquire UScellular Wireless Operations and Deliver Exceptional Value, a Superior 5G Experience and Unparalleled Benefits to Millions of Customers

